Sivakumar M. Nandakumar
Sivakumar M. Nandakumar has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Adarsh Singamsetty
8–11Department of Critical Care Medicine, AIG Hospital, Gachibowli, Hyderabad, Telangana, India
1 shared publication - Akhil Taneja
24,25Department of Critical Care Medicine, Max Super Speciality Hospital, Patparganj & Vaishali, New Delhi, India
1 shared publication - Amol Trimbakrao Kothekar
Department of Anaesthesia, Critical Care and Pain, ACTREC Tata Memorial Center, Homi Bhabha National Institute, Mumbai, Maharashtra, India
1 shared publication - Anand Gupta
Department of Anesthesia and Intensive Care, Asian Institute of Gastroenterology, Hyderabad, India
1 shared publication - Anand Nikalje
Department of Medicine, Medical Centre and Research Institute (MCRI) ICU, MGM Medical College and Hospital, Aurangabad, Maharashtra, India
1 shared publication - Anuj M. Clerk
Department of Intensive Care, Sunshine Global Hospital, Surat, Gujarat, India
1 shared publication
Latest Publications
- 28 December 2025
- Published by Wiley in Nursing in Critical Care
- Vol. 31 (1) , e70265
Impact of Modified Ventilator‐Associated Pneumonia Prevention Bundle on Clinical Parameters and Outcomes Among Mechanically Ventilated Patients: An Interventional Study
Background: Ventilator‐associated pneumonia (VAP) is a significant global health concern and one of the most common healthcare‐associated infections, contributing to increased patient mortality and morbidity. Aim: This study evaluated the impact of a modified VAP prevention bundle on clinical parameters and patient outcomes among individuals receiving mechanical ventilation. Study Design: A quasi‐experimental pretest–posttest study design was adopted. The study was carried out over a period of 18 months in the adult intensive care units of a tertiary care hospital in Coimbatore, India. The intervention group received a modified VAP prevention bundle, whereas the control group received the routine VAP prevention bundle. Data collection was performed using the Modified Clinical Pulmonary Infection Score (mCPIS). Results: A total of 420 patients were recruited through convenience sampling, of whom 56.1% were men. Significant differences were observed between the groups in terms of non‐invasive ventilation (NIV) usage, duration of mechanical ventilation and re‐intubation rates. The intervention group had higher NIV usage, while the mechanical ventilation duration and re‐intubation rate were lower compared to the control group. The overall VAP infection rate after the intervention was 6.19% in the intervention group and 14.29% in the control group [ p = 0.01; OR=2.5; 95% CI (1.3–4.9)], indicating a highly significant reduction. Similarly, the early‐onset VAP rate was 9.3% in the intervention group and 27.9% in the control group. In terms of clinical outcomes, 86.19% of patients in the intervention group and 77.14% in the control group showed improvement. The mortality rate was markedly lower in the intervention group (16.7% vs. 32.56%). Further analysis revealed that increased NIV usage, longer mechanical ventilation duration, higher re‐intubation rates, prolonged ICU stay, extended additional length of stay and longer hospital stay were significant influencing factors for the development of VAP. Conclusion: The modified VAP prevention bundle was effective in reducing the incidence of ventilator‐associated pneumonia. Relevance to Clinical Practice: The modified VAP prevention bundle is effective in reducing the incidence of VAP and improving outcomes among mechanically ventilated patients. As it requires minimal resources and effort, critical care nurses should incorporate this bundle into routine practice to enhance patient safety and quality of care.
- 28 December 2025
- Published by Wiley in Nursing in Critical Care
- Vol. 31 (1) , e70265
Impact of Modified Ventilator‐Associated Pneumonia Prevention Bundle on Clinical Parameters and Outcomes Among Mechanically Ventilated Patients: An Interventional Study
Background: Ventilator‐associated pneumonia (VAP) is a significant global health concern and one of the most common healthcare‐associated infections, contributing to increased patient mortality and morbidity. Aim: This study evaluated the impact of a modified VAP prevention bundle on clinical parameters and patient outcomes among individuals receiving mechanical ventilation. Study Design: A quasi‐experimental pretest–posttest study design was adopted. The study was carried out over a period of 18 months in the adult intensive care units of a tertiary care hospital in Coimbatore, India. The intervention group received a modified VAP prevention bundle, whereas the control group received the routine VAP prevention bundle. Data collection was performed using the Modified Clinical Pulmonary Infection Score (mCPIS). Results: A total of 420 patients were recruited through convenience sampling, of whom 56.1% were men. Significant differences were observed between the groups in terms of non‐invasive ventilation (NIV) usage, duration of mechanical ventilation and re‐intubation rates. The intervention group had higher NIV usage, while the mechanical ventilation duration and re‐intubation rate were lower compared to the control group. The overall VAP infection rate after the intervention was 6.19% in the intervention group and 14.29% in the control group [ p = 0.01; OR=2.5; 95% CI (1.3–4.9)], indicating a highly significant reduction. Similarly, the early‐onset VAP rate was 9.3% in the intervention group and 27.9% in the control group. In terms of clinical outcomes, 86.19% of patients in the intervention group and 77.14% in the control group showed improvement. The mortality rate was markedly lower in the intervention group (16.7% vs. 32.56%). Further analysis revealed that increased NIV usage, longer mechanical ventilation duration, higher re‐intubation rates, prolonged ICU stay, extended additional length of stay and longer hospital stay were significant influencing factors for the development of VAP. Conclusion: The modified VAP prevention bundle was effective in reducing the incidence of ventilator‐associated pneumonia. Relevance to Clinical Practice: The modified VAP prevention bundle is effective in reducing the incidence of VAP and improving outcomes among mechanically ventilated patients. As it requires minimal resources and effort, critical care nurses should incorporate this bundle into routine practice to enhance patient safety and quality of care.
- Open Access
- 30 October 2024
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 28 (11) , 1028-1037
Salt Based or BaLanced SolUtion–Trends Existing in Indian Intensive Care Units: A Multicenter Prospective Observational Cohort Study (SOLUTE Study)
Fluid administration is a commonly practiced intervention in the intensive care unit (ICU) with normal saline being the preferred fluid. We sought to understand the current practice of fluid administration and choice of fluids in Indian ICUs and its effect on renal outcomes. The Indian Society of Critical Care Medicine (ISCCM)-endorsed multicenter prospective observational study was conducted on practice of fluid administration in critically ill patients between May 1, 2020, and January 31, 2023. SPSS software was used for statistical analysis. Private sector hospitals contributed 79.16% of data out of 144 ICUs. Around 961 patients belonged to the normal saline (NS) group, 672 to the Ringer's lactate (RL) group, and 891 to the balanced salt solution (BSS) group out of 2,452 patients. Patients with chronic obstructive pulmonary disease were more in the BSS and NS group as compared to RL group (p < 0.00001). Acute kidney injury (AKI) incidence was higher in the NS group, followed by RL and BSS (p < 0.0001). The serum creatinine rise was higher in the NS group on the first 2 days (p < 0.001). Daily fluid balance, urine output, and renal replacement therapy (RRT) needs were similar among the groups. The BSS group had shorter ICU and hospital length of stay (LOS) than the NS group (p < 0.001). The ICU survival was 63.3% in the NS group and 79.44% in the BSS group (p < 0.001). The AKI patients had higher survival in the BSS group (78.81%) as compared to the NS group (63.08%) (p < 0.001). Balanced salt solution is the preferred intravenous fluid with a safe renal profile among critically ill patients. The AKI patients had shorter hospital and ICU LOS with BSS as compared to NS. Gupta S, Dixit S, Tomar DS, Zirpe K, Govil D, Choudhry D, et al. Salt Based or BaLanced SolUtion–Trends Existing in Indian Intensive Care Units: A Multicenter Prospective Observational Cohort Study (SOLUTE Study). Indian J Crit Care Med 2024;28(11):1028–1037.
- 30 October 2024
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 28 (11) , 1028-1037
Open AccessSalt Based or BaLanced SolUtion–Trends Existing in Indian Intensive Care Units: A Multicenter Prospective Observational Cohort Study (SOLUTE Study)
Fluid administration is a commonly practiced intervention in the intensive care unit (ICU) with normal saline being the preferred fluid. We sought to understand the current practice of fluid administration and choice of fluids in Indian ICUs and its effect on renal outcomes. The Indian Society of Critical Care Medicine (ISCCM)-endorsed multicenter prospective observational study was conducted on practice of fluid administration in critically ill patients between May 1, 2020, and January 31, 2023. SPSS software was used for statistical analysis. Private sector hospitals contributed 79.16% of data out of 144 ICUs. Around 961 patients belonged to the normal saline (NS) group, 672 to the Ringer's lactate (RL) group, and 891 to the balanced salt solution (BSS) group out of 2,452 patients. Patients with chronic obstructive pulmonary disease were more in the BSS and NS group as compared to RL group (p < 0.00001). Acute kidney injury (AKI) incidence was higher in the NS group, followed by RL and BSS (p < 0.0001). The serum creatinine rise was higher in the NS group on the first 2 days (p < 0.001). Daily fluid balance, urine output, and renal replacement therapy (RRT) needs were similar among the groups. The BSS group had shorter ICU and hospital length of stay (LOS) than the NS group (p < 0.001). The ICU survival was 63.3% in the NS group and 79.44% in the BSS group (p < 0.001). The AKI patients had higher survival in the BSS group (78.81%) as compared to the NS group (63.08%) (p < 0.001). Balanced salt solution is the preferred intravenous fluid with a safe renal profile among critically ill patients. The AKI patients had shorter hospital and ICU LOS with BSS as compared to NS. Gupta S, Dixit S, Tomar DS, Zirpe K, Govil D, Choudhry D, et al. Salt Based or BaLanced SolUtion–Trends Existing in Indian Intensive Care Units: A Multicenter Prospective Observational Cohort Study (SOLUTE Study). Indian J Crit Care Med 2024;28(11):1028–1037.
- Open Access
- 10 August 2024
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 28 (S2) , S4
The Indian Society of Critical Care Medicine Position Statement on the Management of Sepsis in Resource-limited Settings
Sepsis poses a significant global health challenge in low- and middle-income countries (LMICs). Several aspects of sepsis management recommended in international guidelines are often difficult or impossible to implement in resource-limited settings (RLS) due to issues related to cost, infrastructure, or lack of trained healthcare workers. The Indian Society of Critical Care Medicine (ISCCM) drafted a position statement for the management of sepsis in RLS focusing on India, facilitated by a task force of 18 intensivists using a Delphi process, to achieve consensus on various aspects of sepsis management which are challenging to implement in RLS. The process involved a comprehensive literature review, controlled feedback, and four iterative surveys conducted between 21 August 2023 and 21 September 2023. The domains addressed in the Delphi process included the need for a position statement, challenges in sepsis management, considerations for diagnosis, patient management while awaiting an intensive care unit (ICU) bed, and treatment of sepsis and septic shock in RLS. Consensus was achieved when 70% or more of the task force members voted either for or against statements using a Likert scale or a multiple-choice question (MCQ). The Delphi process with 100% participation of Task Force members in all rounds, generated consensus in 32 statements (91%) from which 20 clinical practice statements were drafted for the management of sepsis in RLS. The clinical practice statements will complement the existing international guidelines for the management of sepsis and provide valuable insights into tailoring sepsis interventions in the context of RLS, contributing to the global discourse on sepsis management. Future international guidelines should address the management of sepsis in RLS. Juneja D, Nasa P, Chanchalani G, Cherian A, Jagiasi BG, Javeri Y, et al. The Indian Society of Critical Care Medicine Position Statement on the Management of Sepsis in Resource-limited Settings. Indian J Crit Care Med 2024;28(S2):S4-S19.
- 10 August 2024
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 28 (S2) , S4
Open AccessThe Indian Society of Critical Care Medicine Position Statement on the Management of Sepsis in Resource-limited Settings
Sepsis poses a significant global health challenge in low- and middle-income countries (LMICs). Several aspects of sepsis management recommended in international guidelines are often difficult or impossible to implement in resource-limited settings (RLS) due to issues related to cost, infrastructure, or lack of trained healthcare workers. The Indian Society of Critical Care Medicine (ISCCM) drafted a position statement for the management of sepsis in RLS focusing on India, facilitated by a task force of 18 intensivists using a Delphi process, to achieve consensus on various aspects of sepsis management which are challenging to implement in RLS. The process involved a comprehensive literature review, controlled feedback, and four iterative surveys conducted between 21 August 2023 and 21 September 2023. The domains addressed in the Delphi process included the need for a position statement, challenges in sepsis management, considerations for diagnosis, patient management while awaiting an intensive care unit (ICU) bed, and treatment of sepsis and septic shock in RLS. Consensus was achieved when 70% or more of the task force members voted either for or against statements using a Likert scale or a multiple-choice question (MCQ). The Delphi process with 100% participation of Task Force members in all rounds, generated consensus in 32 statements (91%) from which 20 clinical practice statements were drafted for the management of sepsis in RLS. The clinical practice statements will complement the existing international guidelines for the management of sepsis and provide valuable insights into tailoring sepsis interventions in the context of RLS, contributing to the global discourse on sepsis management. Future international guidelines should address the management of sepsis in RLS. Juneja D, Nasa P, Chanchalani G, Cherian A, Jagiasi BG, Javeri Y, et al. The Indian Society of Critical Care Medicine Position Statement on the Management of Sepsis in Resource-limited Settings. Indian J Crit Care Med 2024;28(S2):S4-S19.